Back to Rankings

TLRY

Tilray BrandsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
TLRY vs peer average
15/100
TLRY vs. peer average (F vs. B)
Grade spread
A 3 · B 2 · C 2 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

ZVRA is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $643.17M

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerZVRAZevra Therapeutics
TLRY
Tilray Brands
ZVRA
Zevra Therapeutics
Grade
F
A
Momentum
4
75
Value
52
41
Sentiment
-
70
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs ZVRA

TLRY / ZVRA
Grade Position
Below peers
TLRY vs. peer average (F vs. B)
15/100
Momentum
4
ZVRA
Value
52
TLRY
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs TLRY
1
ZVRA
Zevra Therapeutics Inc Common
A
100/100
-4
2
CLYM
Climb Bio Inc Common
B
80/100
-3
3
CRMD
CorMedix Inc Common
A
100/100
-4
4
ACRS
Aclaris Therapeutics Inc Common
A
100/100
-4
5
SLDB
Solid Biosciences Inc Common
C
60/100
-2
ZVRA is the first peer returned for this comparison set.